Thiyagarajan Devasena (Arul Prakash Francis)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Venues

Pharmaceuticals (Basel, Switzerland)

Pharmaceutics

Drug delivery and translational research

Environmental science and pollution research international

Indian Institute of Technology Madras

Anna University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Indian Institute of Technology Madras Oct 07 2015 - Oct 05 2018

India

Post-Doctoral Fellow :: Department of Biotechnology

Anna University Chennai Faculty of Technology Sep 09 2015 - Oct 06 2015

India

Technology Transfer Fellow :: Centre for Nanoscience and Technology

Anna University Chennai Faculty of Technology Nov 01 2011 - Oct 31 2013

India

Junior Research Fellow :: Centre for Nanoscience and Technology

Education History

Anna University Feb 02 2012 - Apr 10 2015

India

PHD :: Centre for Nanoscience and Technology

Publications

Hema Priya Manivannan, Vishnu Priya Veeraraghavan, Thiyagarajan Devasena
Identification of Novel Marine Bioactive Compound as Potential Multiple Inhibitors in Triple-negative Breast Cancer - An in silico Approach. Current computer-aided drug design (2024)
Dhanalekshmi Unnikrishnan Meenakshi, Gurpreet Kaur Narde, Alka Ahuja, Khalid Al Balushi, Thiyagarajan Devasena, Shah Alam Khan
Therapeutic Applications of Nanoformulated Resveratrol and Quercetin Phytochemicals in Colorectal Cancer-An Updated Review. Pharmaceutics 16 (6) (2024)
Dhanalekshmi Unnikrishnan Meenakshi, Gurpreet Kaur Narde, Alka Ahuja, Khalid Al Balushi, Thiyagarajan Devasena, Shah Alam Khan
Therapeutic Applications of Nanoformulated Resveratrol and Quercetin Phytochemicals in Colorectal Cancer-An Updated Review. Pharmaceutics 16 (6) (2024)
Arul Prakash Francis, Dhanalekshmi Unnikrishnan Meenakshi, Selvam Ganapathy, Thiyagarajan Devasena
Evaluating the ameliorative effect of nano bis-demethoxy curcumin analog against extrapulmonary toxicity in rat induced by inhaled multi-walled carbon nanotube. Environmental science and pollution research international (2023)
Angelene Hannah Jebarani, Renjith Kumar Rasal, Iffath Badsha, Gobi Nallathambi, Thiyagarajan Devasena
Fabrication and optimization of curcumin-multiwalled carbon nanotube (C-MWCNT) conjugate reinforced electrospun polyacrylonitrile membrane for water treatment applications. Environmental science and pollution research international (2023)
Aftab Ahmad, Unnikrishnan Meenakshi Dhanalekshmi, Kailasam Koumaravelu, Thiyagarajan Devasena, Shah Alam Khan, Mohammed F Abuzinadah, Nandakumar Selvasudha
A Study on Pharmacokinetic Functionalities and Safety Margins of an Optimized Simvastatin Nanoformulation. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Tina Sara Biju, Veeraraghavan Vishnu Priya, Thiyagarajan Devasena
Role of three-dimensional cell culture in therapeutics and diagnostics: an updated review. Drug delivery and translational research (2023)
Tina Sara Biju, Veeraraghavan Vishnu Priya, Thiyagarajan Devasena
Role of three-dimensional cell culture in therapeutics and diagnostics: an updated review. Drug delivery and translational research (2023)
Thiyagarajan Devasena, Aftab Ahmad, Sri Durga Devi Nagarajan, Harish Sundar Yogeeswarakannan, Krishnaraj Sekar, Shah Alam Khan, Dhanalekshmi Unnikrishnan Meenakshi, Asif Husain, Mohammed A Bazuhair, Nandakumar Selvasudha
Development of a Novel Red Clay-Based Drug Delivery Carrier to Improve the Therapeutic Efficacy of Acyclovir in the Treatment of Skin Cancer. Pharmaceutics 15 (7) (2023)
Hema Priya Manivannan, Vishnu Priya Veeraraghavan, Thiyagarajan Devasena
Identification of molecular targets of Trigonelline for treating breast cancer through network pharmacology and bioinformatics-based prediction. Molecular diversity (2023)
Aftab Ahmad, Unnikrishnan Meenakshi Dhanalekshmi, Kailasam Koumaravelu, Thiyagarajan Devasena, Shah Alam Khan, Mohammed F Abuzinadah, Nandakumar Selvasudha
A Study on Pharmacokinetic Functionalities and Safety Margins of an Optimized Simvastatin Nanoformulation. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Aftab Ahmad, Unnikrishnan Meenakshi Dhanalekshmi, Kailasam Koumaravelu, Thiyagarajan Devasena, Shah Alam Khan, Mohammed F Abuzinadah, Nandakumar Selvasudha
A Study on Pharmacokinetic Functionalities and Safety Margins of an Optimized Simvastatin Nanoformulation. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Thiyagarajan Devasena, A Jayakrishnan
Conjugating doxorubicin to polymannose: a new strategy for target specific delivery to lung cancer cells. Journal of biomaterials science. Polymer edition 30 (16) (2019)

Thiyagarajan Devasena.css-eqlu8i{font-size:small;padding-left:4px;} (Arul Prakash Francis)

Publication Activity (10 Years)

Top Topics

Top Venues

Thiyagarajan Devasena (Arul Prakash Francis)